FDA has finalized guidance to help facilities determine their business size under the Preventive Controls for Human Food and Preventive Controls for Animal Food rules issued in response to the FSMA.
Many foodborne illnesses occur because a link in the cold food chain was weak or broken, with temperature inconsistencies that allowed pathogens to begin growing.
Many processors have grown more sophisticated at compiling information and presenting it when inspectors ask for proof that a facility's food safety management system is working. But no matter the companies’ size or record management methods, they likely experience some of the common deficiencies that experts see.
FDA intends to exercise this enforcement discretion to provide industry with greater flexibility when labeling food products, including those formulated to reduce sodium content.
The FDA held a public hearing on May 31 to solicit oral presentations and comments in order to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of products containing cannabis or cannabis-derived products.
USDA's FSIS and FDA released a formal agreement to address the regulatory oversight of human food products derived from the cells of livestock and poultry, which describes the oversight roles and responsibilities for both agencies and how they will collaborate to regulate the development and entry of these products into commerce.
The USDA's National List of Allowed and Prohibited Substances (National List) for organic regulations has been amended to implement recommendations submitted to the secretary of agriculture by the NOSB.
